Whether you need quick hydration or a more targeted treatment for specific conditions, we are here to provide a safe, comfortable, and efficient experience
437,438 Sacituzumab govitecan (SG) received its first FDA approval for treating metastatic TNBC patients according to the results of the ASCENT trial
Ethical statement This study was carried out in strict accordance with the recommendations in the CARE and PRISMA guidelines
doi: 10.3389/fimmu.2025.1578940 Received 18 February 2025 Accepted 24 March 2025 Published 10 April 2025 Volume 16 - 2025 Edited by Fabrizio Fontana, University of Milan, Italy Reviewed by Bjrn Steen Sklhegg, University of Oslo, Norway Josephine Anthony, Meenakshi Academy of Higher Education and Research, India Updates Copyright 2025 Fang, Gao, Jiang, Li and Li